SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Desh Rakshak Aushdhalaya informs about submission of notice of 44th AGM

06 Dec 2025 Evaluate
Pursuant to Para A of Part A of Schedule III and Regulation 30 and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Securities and Exchange Board of India (SEBI) Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th day of November, 2024 and SEBI Circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th day of July, 2023, Desh Rakshak Aushdhalaya Desh Rakshak Aushdhalaya has informed that the Board of Directors of the Company in the board meeting held on Saturday 06th day of December, 2025 approved Notice of 44th Annual General Meeting of the Company scheduled to be held on Tuesday, 30th December, 2025 at 03:00 PM at Bhagwant Kuti Kankhal, Haridwar, Uttarakhand-249408. Pursuant to para A of Part A of schedule III read with Regulation 30 and pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company are attached Notice of the 44th Annual General Meeting for the Financial year 2024-2025. The said notice is also available on the website of the company i.e. www.deshrakshak.in. Time of commencement and conclusion of board meeting is 10:00 AM to 12:20 PM. i.e. date & time of occurrence of the event/information is 06.12.2025 at 12:20 PM. The details as required under Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th day of November, 2024 and SEBI Circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th day of July, 2023 are enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE. 

Desh Rakshak Aushdh Share Price

24.55 -1.20 (-4.66%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×